Latest news with #EncompassHealth
Yahoo
23-05-2025
- Health
- Yahoo
EHC Opens Rehabilitation Unit in Fort Myers, Boosts Florida Footprint
Encompass Health Corporation EHC recently inaugurated the Rehabilitation Hospital of Fort Myers, a healthcare facility built as a result of its joint venture partnership with Florida-based Lee Health. The partners joined forces back in 2022 to jointly operate two inpatient rehabilitation hospitals in Southwest Florida, one in Cape Coral and the other one in Fort Myers. Encompass Health Rehabilitation Hospital of Cape Coral commenced operations almost within the targeted timeline in 2022. Initially, the Fort Myers facility was expected to be functional in 2024 but during the groundbreaking ceremony of the joint venture hospital in March 2024, the inauguration timeline was revealed to be summer 2025. The Rehabilitation Hospital of Fort Myers is equipped with 60 beds and features private patient rooms, a modern therapy gym with cutting-edge technology, a therapy courtyard, a daily living suite, an in-house dialysis unit and several other lucrative amenities. A multidisciplinary team of specialized nurses, therapists and physicians will deliver tailored physical, occupational and speech therapies to patients recovering from strokes, brain and spinal cord injuries, amputations and complex orthopedic conditions. Patients will benefit from at least three hours of intensive therapy five days a week, regular physician visits and 24-hour nursing support. Such enhanced rehabilitation services will enable patients to resume daily life activities and bring about improved health outcomes across the Fort Myers area. The recent partnership is reflective of EHC's efforts to boost its presence in Florida. The company already boasts a well-established presence in the state and the Fort Myers hospital marks its 22nd facility across Florida. Lee Health, which has more than 10 decades of experience in catering to the health needs of Florida residents, seems to be the apt partner for complementing Encompass Health's endeavor. This month itself, EHC unveiled early-stage plans to build a new 50-bed inpatient rehabilitation hospital in Apollo Beach, FL. EHC has been able to substantiate the credibility of its affordable and high-quality inpatient rehabilitative services across 38 states and Puerto Rico, as a result of which it remains the trusted partner for several healthcare providers. Joint ventures with regional healthcare providers are beneficial for Encompass Health since they serve as a means to gain an in-depth knowledge of the diversified healthcare needs of a particular region. The latest hospital opening takes the overall count of Encompass Health's inpatient rehabilitation hospitals to 168. The company follows a remarkable expansion endeavor of opening such facilities throughout the year. An increase in the facility count is likely to provide an opportunity for EHC to treat more patients and bring higher revenues. Revenues improved 10.6% year over year in the first quarter of 2025. Management estimates operating revenues to lie between $5.85 billion and $5.925 billion for 2025, the midpoint of which indicates a 9.6% rise from the 2024 reported figure. Shares of Encompass Health have gained 42.6% in the past year compared with the industry's growth of 5.7%. EHC currently sports a Zacks Rank #1 (Strong Buy). Image Source: Zacks Investment Research Some other top-ranked stocks in the Medical space are CorMedix Inc. CRMD, BioLife Solutions, Inc. BLFS and Integer Holdings Corporation ITGR, each sporting a Zacks Rank #1 at present. You can see the complete list of today's Zacks #1 Rank stocks here. CorMedix's earnings surpassed estimates in each of the last four quarters, the average surprise being 25.82%. The Zacks Consensus Estimate for CRMD's 2025 earnings is pegged at 93 cents per share. A loss of 30 cents per share was incurred in the prior year. The consensus mark for revenues indicates a nearly four-fold increase from the year-ago actual. The consensus mark for CRMD's earnings has moved 40.9% north in the past 30 bottom line of BioLife Solutions outpaced estimates in each of the trailing four quarters, the average surprise being 112.90%. The Zacks Consensus Estimate for BLFS' 2025 earnings is pegged at 2 cents per share. A loss of 7 cents per share was incurred in the prior year. BLFS witnessed one upward estimate revision for 2025 earnings against none downward over the past 30 days. Integer's earnings outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 2.77%. The Zacks Consensus Estimate for ITGR's 2025 earnings indicates a rise of 19.4% from the prior-year tally. The consensus mark for revenues indicates a 7.7% increase from the year-ago actual. The consensus mark for ITGR's earnings has moved up 1.1% in the past seven days. Shares of CorMedix and BioLife Solutions have gained 143% and 3.1%, respectively, in the past year. However, Integer stock has declined 1.5% in the same time frame. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BioLife Solutions, Inc. (BLFS) : Free Stock Analysis Report CorMedix Inc (CRMD) : Free Stock Analysis Report Integer Holdings Corporation (ITGR) : Free Stock Analysis Report Encompass Health Corporation (EHC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
22-05-2025
- Business
- Yahoo
3 Low-Volatility Stocks Walking a Fine Line
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. Choosing the wrong investments can cause you to fall behind, which is why we started StockStory - to separate the winners from the losers. Keeping that in mind, here are three low-volatility stocks that don't make the cut and some better opportunities instead. Rolling One-Year Beta: 0.79 Founded in 1920, Snap-on (NYSE:SNA) is a global provider of tools, equipment, and diagnostics for various industries such as vehicle repair, aerospace, and the military. Why Do We Think Twice About SNA? Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion 6.3 percentage point decline in its free cash flow margin over the last five years reflects the company's increased investments to defend its market position Diminishing returns on capital suggest its earlier profit pools are drying up At $322.12 per share, Snap-on trades at 16.1x forward P/E. To fully understand why you should be careful with SNA, check out our full research report (it's free). Rolling One-Year Beta: 0.61 With a network of 161 specialized facilities across 37 states and Puerto Rico, Encompass Health (NYSE:EHC) operates inpatient rehabilitation hospitals that help patients recover from strokes, hip fractures, and other debilitating conditions. Why Is EHC Not Exciting? Expenses have increased as a percentage of revenue over the last two years as its adjusted operating margin fell by 4 percentage points Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 2.2 percentage points Encompass Health's stock price of $119.01 implies a valuation ratio of 24.4x forward P/E. Check out our free in-depth research report to learn more about why EHC doesn't pass our bar. Rolling One-Year Beta: 0.91 With over 2,500 research experts guiding organizations through complex technology landscapes, Gartner (NYSE:IT) provides research, advisory services, and conferences that help executives make better decisions about technology and other business priorities. Why Are We Hesitant About IT? Earnings growth over the last two years fell short of the peer group average as its EPS only increased by 9.3% annually Gartner is trading at $442.91 per share, or 35.7x forward P/E. If you're considering IT for your portfolio, see our FREE research report to learn more. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Error while retrieving data Sign in to access your portfolio Error while retrieving data
Yahoo
20-05-2025
- Health
- Yahoo
Rehabilitation Hospital of Fort Myers now open in Florida
The 60-bed inpatient rehabilitation hospital is a joint venture between Encompass Health and Lee Health. BIRMINGHAM, Ala. and FORT MYERS, Fla., May 20, 2025 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, along with Lee Health, a century-long health care provider in the Southwest Florida community, announced the opening of Rehabilitation Hospital of Fort Myers. The 60-bed inpatient rehabilitation hospital is located at 6150 Medical Park Loop in Fort Myers, Florida. The hospital provides essential rehabilitative services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain function and independence. Patients receive a minimum of three hours of intensive therapy five days each week, frequent physician visits and 24-hour nursing care. "Our talented team is excited to serve the Fort Myers community," said José Rosado, CEO of Rehabilitation Hospital of Fort Myers. "The compassionate, high-quality care we provide will help patients reach their unique rehabilitation goals and return to what matters most." Hospital amenities include all private patient rooms, a spacious therapy gym featuring advanced rehabilitation technologies, an activities of daily living suite, in-house dialysis suite, therapy courtyard, dining room, in-house pharmacy and dayroom areas. An interdisciplinary team of highly specialized nurses, therapists and physicians will provide physical, occupational and speech therapies to restore functional ability and quality of life. "The opening of the Rehabilitation Hospital of Fort Myers marks a significant milestone in expanding access to high-quality rehabilitative care in our region," said Ben Spence, Chief Operating and Financial Officer of Lee Health. "Through our partnership with Encompass Health, we're proud to bring advanced, patient-centered rehabilitation services to the community, helping individuals recover and thrive close to home." "We are pleased to partner with Lee Health, a health system that shares our commitment to building trust in the communities we serve," said Lori Bedard, President of Encompass Health's Southeast region. "We look forward to positively impacting the lives of many in the Fort Myers community." Rehabilitation Hospital of Fort Myers is Encompass Health's 168th inpatient rehabilitation hospital nationwide and its 22nd location in Florida. For more information about the hospital's services, visit About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 168 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies™, Becker's Hospital Review's 150 Top Places to Work in Healthcare and Forbes' Most Trusted Companies in America. For more information, visit or follow us on our newsroom, X, Instagram and Facebook. From Fortune. © 2025 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. From Forbes © 2024 Forbes Media LLC. All rights reserved. Used under license. About Lee HealthSince the opening of the first hospital in 1916, Lee Health has been a health care leader in Southwest Florida, constantly evolving to meet the needs of the community. A non-profit, integrated health care services organization, Lee Health is committed to the well-being of every individual served, focused on healthy living and maintaining good health. Health care services are conveniently located throughout the community in four acute care hospitals, two specialty hospitals, outpatient centers, walk-in medical centers, primary care and specialty physician practices and other services across the continuum of care. Learn more at Encompass Health media contact:Polly Manuel | 205-970-5912media@ Lee Health media contactJaclyn Bevis | 317-809-1705media@ View original content to download multimedia: SOURCE Encompass Health Corp. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-05-2025
- Business
- Yahoo
Encompass Health announces preliminary plans to build a 50-bed inpatient rehabilitation hospital in Apollo Beach, Florida
BIRMINGHAM, Ala. and APOLLO BEACH, Fla., May 12, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in the master-planned community of Waterset in Apollo Beach, Florida. The hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing care, the hospital will offer physical, occupational and speech therapies to restore functional ability and quality of life. Care will be provided by highly specialized nurses, therapists and physicians. The hospital will feature private patient rooms, a spacious therapy gym with advanced rehabilitation technologies and an activities of daily living suite, in-house dialysis suite, dining room, pharmacy and therapy courtyard. "We are excited to expand Encompass Health's presence in Florida to serve patients in the Apollo Beach area closer to home," said Lori Bedard, president of Encompass Health's Southeast region. "We look forward to providing high-quality, compassionate and individualized inpatient rehabilitative care to help patients reach their highest level of independence." The hospital, expected to open in 2027, will be part of Encompass Health's national network of rehabilitation hospitals and its ongoing expansion in Florida. About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 167 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies™, Becker's Hospital Review's 150 Top Places to Work in Healthcare and Forbes' Most Trusted Companies in America. For more information, visit or follow us on our newsroom, X, Instagram and Facebook. From Fortune. © 2025 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. From Forbes © 2024 Forbes Media LLC. All rights reserved. Used under license. Forward-Looking StatementsStatements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including development and maintenance of relationships with referral sources; disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended Dec. 31, 2024 and 10-Q for the period ended March 31, 2025. Media contact:Polly Manuel | 205-970-5912media@ Investor Relations contact:Mark Miller | View original content to download multimedia: SOURCE Encompass Health Corp. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
05-05-2025
- Business
- Yahoo
2 Surging Stocks on Our Watchlist and 1 to Avoid
Exciting developments are taking place for the stocks in this article. They've all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns. However, not all companies with momentum are long-term winners, and many investors have lost money by following short-term trends. All that said, here are two stocks we think live up to the hype and one best left ignored. One-Month Return: +20.6% With a network of 161 specialized facilities across 37 states and Puerto Rico, Encompass Health (NYSE:EHC) operates inpatient rehabilitation hospitals that help patients recover from strokes, hip fractures, and other debilitating conditions. Why Does EHC Give Us Pause? Expenses have increased as a percentage of revenue over the last two years as its adjusted operating margin fell by 4 percentage points Annual earnings per share growth of 4.6% underperformed its revenue over the last five years, showing its incremental sales were less profitable Free cash flow margin dropped by 2.2 percentage points over the last five years, implying the company became more capital intensive as competition picked up Encompass Health is trading at $116.64 per share, or 23.8x forward P/E. If you're considering EHC for your portfolio, see our FREE research report to learn more. One-Month Return: +33.1% The developer of the world's first frost-proof water meter in 1905, Badger Meter (NYSE:BMI) provides water control and measure equipment to various industries. Why Will BMI Outperform? Annual revenue growth of 20% over the last two years was superb and indicates its market share increased during this cycle Earnings per share have massively outperformed its peers over the last two years, increasing by 36.6% annually Strong free cash flow margin of 15.3% enables it to reinvest or return capital consistently At $230.05 per share, Badger Meter trades at 48.9x forward P/E. Is now the time to initiate a position? Find out in our full research report, it's free. One-Month Return: +40.7% Developing submarine detection systems for the U.S. Navy, Leonardo DRS (NASDAQ:DRS) is a provider of defense systems, electronics, and military support services. Why Should DRS Be on Your Watchlist? Sales pipeline is in good shape as its backlog averaged 54.4% growth over the past two years Incremental sales over the last two years have been highly profitable as its earnings per share increased by 18% annually, topping its revenue gains Free cash flow margin expanded by 4.7 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends Leonardo DRS's stock price of $42.93 implies a valuation ratio of 38.6x forward P/E. Is now the right time to buy? See for yourself in our full research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Axon (+711% five-year return). Find your next big winner with StockStory today for free.
